First, the transition from NAFLD to NASH correlates with the accumulation of hepatic cholesterol crystals, a known NLRP3 trigger (Duewell et al., 2010; Ioannou et al., 2013). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.